Stephen Connelly

Stephen Connelly

Company: Equillium Inc.

Job title: Co-Founder, CSO


Targeting Biological Synergy At the Receptor Level – Multi-specific Cytokine Inhibitors 9:30 am

• Design and Development of multi-specific cytokine inhibitors • Importance of targeting biological synergy to optimize therapeutic outcomes • Advancing candidates into the clinic and beyondRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.